Allied Market Research published a report, titled, “Single Cell Analysis Marketย By Product (Consumables, Instruments), By Techniques (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Mass Spectrometry, Others), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Others), By Application (Oncology, Immunology, Neurology, Stem cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization (IVF), Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.”
๐น๐๐๐๐๐๐ ๐บ๐๐๐๐๐ ๐ช๐๐๐ ๐๐ ๐น๐๐๐๐๐-ย https://www.alliedmarketresearch.com/request-sample/A06188
๐ซ๐๐๐๐๐๐, ๐๐๐๐๐๐๐๐๐๐, ๐๐๐
๐๐๐๐๐๐๐๐๐๐๐๐๐:
The global single cell analysis market is experiencing significant growth, propelled by heightened demand and advancements in technology, particularly in the pharmaceutical and biotechnology sectors. This growth is further fueled by increased research and development activities. Additionally, there’s a growing emphasis on personalized medicines and a rising incidence of cancer, which contribute to the market expansion. However, the high cost of single cell analysis products poses a challenge to growth. Nonetheless, the burgeoning potential of single cell sequencing offers promising opportunities for lucrative expansion in the industry.
๐๐ก๐ ๐๐จ๐ง๐ฌ๐ฎ๐ฆ๐๐๐ฅ๐๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐๐จ๐ฆ๐ข๐ง๐๐ญ๐ ๐๐ฒ 2031:
In 2021, the consumables segment dominated the global single cell analysis market, accounting for approximately two-thirds of the market share, a trend expected to continue through 2031. Furthermore, this segment is projected to experience the fastest compound annual growth rate (CAGR) of 17.9% from 2022 to 2031. This growth can be attributed to the widespread usability of products, regular procurement of reagents, rising incidence of target diseases, and the continuous demand for consumables essential for assays.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ-ย https://www.alliedmarketresearch.com/purchase-enquiry/6553
๐ป๐๐ ๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐ (๐ต๐ฎ๐บ) ๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐ ๐๐๐๐’๐ ๐๐๐๐๐:
In 2021, the Next Generation Sequencing (NGS) technique accounted for approximately one-third of the total revenue in the global single cell analysis market, a trend projected to persist through 2031. Moreover, this segment is anticipated to demonstrate the fastest compound annual growth rate (CAGR) of 18.0% from 2022 to 2031. This growth is attributed to the escalation of genome mapping programs, expanded applications of next-generation sequencing, a surge in healthcare spending, and advancements in sequencing platform technologies.
๐๐ก๐ ๐จ๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ซ๐ฎ๐ฅ๐ ๐ญ๐ก๐ ๐ซ๐จ๐จ๐ฌ๐ญ:
In 2021, the oncology segment accounted for over one-third of the global single cell analysis market share and is poised to maintain its leading position through 2031. This dominance is fueled by the proven efficacy of single cell analysis in early cancer cell diagnostics, propelling segment growth. Conversely, the neurology segment is forecasted to demonstrate the highest compound annual growth rate (CAGR) of 18.8% from 2022 to 2031, attributed to the growing prevalence of neurological disorders.
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ ๐๐ซ๐ง๐๐ซ๐๐ ๐ญ๐ก๐ ๐ฆ๐๐ฃ๐จ๐ซ ๐ฌ๐ก๐๐ซ๐ ๐ข๐ง 2021:
In 2021, North America dominated the global single cell analysis market, accounting for nearly half of its total share. This was driven by the region’s well-established healthcare system, a growing population of elderly patients, and supportive reimbursement policies, all contributing to market growth. Conversely, Europe is projected to experience the fastest compound annual growth rate (CAGR) of 21.6% by 2031. This growth is fueled by increasing cancer incidences and heightened government funding for single cell analysis research. The report also examines other regions such as Asia-Pacific and LAMEA.
๐๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:
Danaher Corporation
Becton
Merck KGAA
QIAGEN N.V.
Illumina, Inc.
Thermo Fisher Scientific, Inc.
BGI Genomics Co.Ltd.
Dickinson and Company
Agilent Technologies, Inc.,
Sartorius AG
Takara Holdingsinc
Oxford Nanopore Technologies.
10x Genomics
Bio-Rad Laboratories
Berkley Light INC.
Dolomite Bio
Standard Biotools
Diasorin Group
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
